Phyjama

A key challenge that has emerged in recent years is the ability to remotely monitor patients, particularly elderly individuals while they are at home. This is particularly important given demographic shifts; the WHO estimates that the global share of the population aged 65 years or over increased from 6 percent in 1990 to 9 percent in 2019, and is projected to increase to 16 percent in the next two decades [1]. While the increase in life expectancy is a tremendous achievement, it also presents a growing need to go beyond episodic measurement collected in clinical settings to continuous monitoring at home. Indeed, this issue has become particularly acute in recent times in light of the COVID-19 pandemic and the need to ensure timely treatment delivery while at the same time protecting elderly from exposure to the virus and alleviating burden on support staff.